Evidence map›Paper›PMID 34057286›Full record

Observational studyTherapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy2022

Favorable therapeutic efficacy of low-density lipoprotein apheresis for nephrotic syndrome with impaired renal function.

Eri Muso, Soichi Sakai, Youske Ogura, Susumu Yukawa, Yoshiki Nishizawa, Noriaki Yorioka, Takao Saito, Masatoshi Mune, Satoshi Sugiyama, Yasuhiko Iino and 22 more

Open access · hybridAbstract readMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Favorable therapeutic efficacy of low-density lipoprotein apheresis for nephrotic syndrome with impaired renal function.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2022
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 1 country.

Eri MusoDepartment of Food and Nutrition, Faculty of Contemporary Home Economics, Kyoto Kacho University, Kyoto, Japan.ORCID https://orcid.org/0000-0002-1150-7419
Soichi SakaiSiratori Clinic, Tokyo, Japan.
Youske OguraZenjinkai Ueno Hospital, Tokyo, Japan.
Susumu YukawaHakubunnkai Kodama Hospital, Wakayama, Japan.
Yoshiki NishizawaUniversity Public Corporation Osaka, Osaka, Japan.
Noriaki YoriokaHiroshima Kidney Organization, Hiroshima, Japan.
Takao SaitoSanko Clinic, Fukuoka, Japan.
Masatoshi MuneRyoshukai Fujii Hospital, Kishiwada, Japan.
Satoshi SugiyamaKanayama Clinic, Nagoya, Japan.
Yasuhiko IinoTokyo Medical School, Tokyo, Japan.
Tsutomu HiranoDiabetes Center, Ebina General Hospital, Ebina, Japan.
Motoshi HattoriDepartment of Pediatric Nephrology, Tokyo Women's Medical University, Tokyo, Japan.
Tsuyoshi WatanabeTokyo-kita Medical Center, Tokyo, Japan.
Hitoshi YokoyamaDepartment of Nephrology, Kanazawa Medical University School of Medicine, Uchinada, Japan.
Hiroshi SatoSendai Hospital of East Japan Railway Company, Sendai, Japan.
Shunya UchidaDepartment of Health Care, Teikyo Heisei University, Tokyo, Japan.
Takashi WadaDepartment of Nephrology and Laboratory Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Faculty of Medicine, Kanazawa University, Kanazawa, Japan.
Tetsuo ShojiDepartment of Vascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.ORCID https://orcid.org/0000-0003-3953-0925
Hiroaki OdaOda Clinic, Hiroshima, Japan.
Kiyoshi MoriSchool of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Hideki KimuraDepartment of Clinical Laboratory, University of Fukui Hospital, Fukui, Japan.
Osamu ItoDivision of General Medicine and Rehabilitation, Tohoku Medical and Pharmaceutical University Faculty of Medicine, Sendai, Japan.
Akira NishiyamaDepartment of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Shoichi MaruyamaDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Reiko InagiDivision of CKD Pathophysiology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Shoichi FujimotoDepartment of Hemovascular Medicine and Artificial Organs, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Tatsuo TsukamotoDepartment of Nephrology and Dialysis, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Japan.
Yusuke SuzukiDepartment of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Hirokazu HondaDepartment of Medicine, Division of Nephrology, Showa University School of Medicine, Tokyo, Japan.
Tetsuya BabazonoDepartment of Medicine, Diabetes Center, School of Medicine, Tokyo Women's Medical University, Tokyo, Japan.ORCID https://orcid.org/0000-0001-8545-3604
Kazuhiko TsuruyaDepartment of Nephrology, Nara Medical University, Kashiwara, Japan.
Yukio YuzawaDepartment of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.
Ono Clinic · JPTokyo Women's Medical University · JPEast Japan Railway (Japan) · JPEbina General Hospital · JPFujita Health University · JPHattori Botanical Laboratory · JPHiroshima Prefectural Rehabilitation Center · JPJuntendo University · JPKagawa University · JPKanazawa Medical University · JPKanazawa University · JPKihoku hospital · JPKitano Hospital · JPKyoto Kacho University · JPNagoya University · JPNara Medical University · JPOkayama Psychiatric Medical Center · JPOsaka City University · JPOsaka Prefectural Institute of Public Health · JPSan-ikukai Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many reports have shown the therapeutic efficacy of LDL apheresis (LDL-A) in drug-resistant nephrotic syndrome (NS) for improvement of heavy proteinuria and severely impaired renal function. To obtain comprehensive results in a large number of cases, a post hoc analysis of the Prospective Observational survey on the Long-Term Effects of the LDL-Apheresis on the Drug Resistant Nephrotic Syndrome (POLARIS) study was performed by stratifying enrolled cases according to the pretreatment estimated glomerular filtration rate (eGFR) levels indicating normal (N) (≥60 ml/min/1.73 m

Indexed as

Blood Component RemovalCohort StudiesHumansLipoproteins, LDLNephrotic SyndromeProspective StudiesRenal InsufficiencyTreatment OutcomeLipoproteins, LDLeGFRend-stage renal diseaseLDL apheresisnephrotic syndromerenal dysfunction

Identifiers

PMID34057286
PMCPMC9290660
OpenAlexW3164726819

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.